+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cyclophosphamide"

From
Urethral Cancer Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Urethral Cancer Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 196 Pages
  • Global
From
Ovarian Cancer Drugs Market Report 2026 - Product Thumbnail Image

Ovarian Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Alkylating Agents Market Report 2026 - Product Thumbnail Image

Alkylating Agents Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Immunoglobulin a IgA Vasculitis Market Report 2026 - Product Thumbnail Image

Immunoglobulin a IgA Vasculitis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Medulloblastoma Drug Market Report 2026 - Product Thumbnail Image

Medulloblastoma Drug Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Gestational Trophoblastic Disease Market Report 2026 - Product Thumbnail Image

Gestational Trophoblastic Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
High Purity Alkylating Agents Market Report 2026 - Product Thumbnail Image

High Purity Alkylating Agents Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Gynecological Cancer Drugs Market Report 2026 - Product Thumbnail Image

Gynecological Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Injectable Cytotoxic Drugs Market Report 2026 - Product Thumbnail Image

Injectable Cytotoxic Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Generic Oncology Drugs Market Report 2026 - Product Thumbnail Image

Generic Oncology Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Antineoplastic Agents - Global Strategic Business Report - Product Thumbnail Image

Antineoplastic Agents - Global Strategic Business Report

  • Report
  • May 2026
  • 183 Pages
  • Global
From
From
From
Lupus Nephritis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Lupus Nephritis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
Scleroderma Pipeline Analysis Report 2025 - Product Thumbnail Image

Scleroderma Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
Loading Indicator

Cyclophosphamide is a drug used to treat immune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and vasculitis. It is a type of alkylating agent, which works by inhibiting the growth of certain cells in the body. It is usually administered intravenously or orally, and is often used in combination with other drugs. Cyclophosphamide is also used to treat certain types of cancer, such as lymphoma and leukemia. Cyclophosphamide is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as bone marrow suppression, and should be used with caution. Some of the companies in the Cyclophosphamide market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Show Less Read more